Cargando…

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts

Detalles Bibliográficos
Autores principales: Fischer, Suzanne, Creytens, David, De Geyter, Sofie, De Vlieghere, Elly, Pattyn, Piet, Bekaert, Sarah‐Lee, Durinck, Kaat, Van Roy, Nadine, Hendrix, An, Lapeire, Lore, Sys, Gwen, De Wever, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244893/
https://www.ncbi.nlm.nih.gov/pubmed/37282823
http://dx.doi.org/10.1002/ctm2.1290
_version_ 1785054747067154432
author Fischer, Suzanne
Creytens, David
De Geyter, Sofie
De Vlieghere, Elly
Pattyn, Piet
Bekaert, Sarah‐Lee
Durinck, Kaat
Van Roy, Nadine
Hendrix, An
Lapeire, Lore
Sys, Gwen
De Wever, Olivier
author_facet Fischer, Suzanne
Creytens, David
De Geyter, Sofie
De Vlieghere, Elly
Pattyn, Piet
Bekaert, Sarah‐Lee
Durinck, Kaat
Van Roy, Nadine
Hendrix, An
Lapeire, Lore
Sys, Gwen
De Wever, Olivier
author_sort Fischer, Suzanne
collection PubMed
description
format Online
Article
Text
id pubmed-10244893
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102448932023-06-08 Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts Fischer, Suzanne Creytens, David De Geyter, Sofie De Vlieghere, Elly Pattyn, Piet Bekaert, Sarah‐Lee Durinck, Kaat Van Roy, Nadine Hendrix, An Lapeire, Lore Sys, Gwen De Wever, Olivier Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-06-06 /pmc/articles/PMC10244893/ /pubmed/37282823 http://dx.doi.org/10.1002/ctm2.1290 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Fischer, Suzanne
Creytens, David
De Geyter, Sofie
De Vlieghere, Elly
Pattyn, Piet
Bekaert, Sarah‐Lee
Durinck, Kaat
Van Roy, Nadine
Hendrix, An
Lapeire, Lore
Sys, Gwen
De Wever, Olivier
Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
title Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
title_full Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
title_fullStr Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
title_full_unstemmed Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
title_short Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
title_sort post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244893/
https://www.ncbi.nlm.nih.gov/pubmed/37282823
http://dx.doi.org/10.1002/ctm2.1290
work_keys_str_mv AT fischersuzanne postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT creytensdavid postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT degeytersofie postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT devlieghereelly postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT pattynpiet postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT bekaertsarahlee postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT durinckkaat postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT vanroynadine postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT hendrixan postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT lapeirelore postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT sysgwen postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts
AT deweverolivier postoperativeminimalresidualdiseasemodelstostudymetastaticrelapseinsofttissuesarcomapatientderivedxenografts